BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2002
View Archived Issues
Inhibitors of AChE and BuChE with trypsin-activating effects for use in AD
Read More
Novel GH secretagogues identified at Sumitomo
Read More
Procyon presents new protein kinase C modulators for inflammation and psoriasis
Read More
Sumitomo researchers describe hypolipidemic compounds with LDL receptor-upregulating activity
Read More
Novel agents for urinary incontinence covered by Boehringer Ingelheim patent
Read More
New factor Xa inhibitors in development at Lilly
Read More
MMP inhibitors for use in cancer, COPD, asthma and brain edema prepared at Novartis
Read More
Pregabalin reported to improve GAD symptoms
Read More
Kos files sNDA for Niaspan for reducing risk of stroke
Read More
Potential use of metyrapone as an adjunct in major depression
Read More
Additional data on atomoxetine in ADHD discussed in Barcelona
Read More
Possible new indications for gabapentin
Read More
Thuris and D-Pharm initiate feasibility project
Read More
M-Vax and O-Vax INDs cleared
Read More
Adenosine A2A receptor agonist promotes wound healing: topical CGS-21680 effective in mice
Read More
YM-598 effective against diabetic nephropathy in a rat model of type 2 diabetes
Read More
NF-kB decoy oligodeoxynucleotide prevents and induces regression of atopic dermatitis in mice
Read More
Ciclosporin-loaded microspheres assessed for efficacy and safety in corneal rejection model
Read More
Naturally produced antibiotic is a promising anti-TB drug candidate
Read More
Conformationally constrained oxazolidinones evaluated for SAR
Read More
Potential antibacterial agents from PanTherix target chorismate synthase
Read More
First PDF inhibitor enters human testing; several ICAAC presentations cover these novel agents
Read More
Avandamet approved for type 2 diabetes
Read More
Lipitor shows significant benefit in reducing heart attacks and stroke in ASCOT trial
Read More
Celera Diagnostics and Bristol-Myers Squibb collaborate on cardiovascular disease and diabetes
Read More
Epidex receives humanitarian use device designation
Read More
Approvable letter for Vanlev
Read More